These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8969315)

  • 1. The consequence of production loss or increased costs of production.
    Koopmanschap MA; Rutten FF
    Med Care; 1996 Dec; 34(12 Suppl):DS59-68. PubMed ID: 8969315
    [No Abstract]   [Full Text] [Related]  

  • 2. The proper role for discounting. Search in progress.
    Lipscomb J
    Med Care; 1996 Dec; 34(12 Suppl):DS119-23. PubMed ID: 8969320
    [No Abstract]   [Full Text] [Related]  

  • 3. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands.
    Hakkaart-van Roijen L; Hoeijenbos MB; Regeer EJ; ten Have M; Nolen WA; Veraart CP; Rutten FF
    Acta Psychiatr Scand; 2004 Nov; 110(5):383-92. PubMed ID: 15458562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective cost-effectiveness analysis of vertical banded gastroplasty for the treatment of morbid obesity.
    van Gemert WG; Adang EM; Kop M; Vos G; Greve JW; Soeters PB
    Obes Surg; 1999 Oct; 9(5):484-91. PubMed ID: 10605908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health outcomes analysis and its applications].
    Carrera-Hueso FJ
    Rev Med Univ Navarra; 1997; 41(4):237-44. PubMed ID: 10420964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluations and diabetes.
    Pathak DS; Burke TA
    Pharm Pract Manag Q; 1998 Jan; 17(4):17-24. PubMed ID: 10174745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of neonatal surgery: a review.
    Stolk EA; Post HA; Rutten FF; Molenaar JC; Busschbach JJ
    J Pediatr Surg; 2000 Apr; 35(4):588-92. PubMed ID: 10770388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of patient care in children with meningeal signs.
    Oostenbrink R; Oostenbrink JB; Moons KG; Derksen-Lubsen G; Essink-Bot ML; Grobbee DE; Redekop WK; Moll HA
    Int J Technol Assess Health Care; 2002; 18(3):485-96. PubMed ID: 12391942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionic versus nonionic contrast media: a burden or a bargain?
    Gafni A; Zylak CJ
    CMAJ; 1990 Sep; 143(6):475-8. PubMed ID: 2119871
    [No Abstract]   [Full Text] [Related]  

  • 13. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
    Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
    J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current principles and application of pharmacoeconomics.
    Malek M
    Pharmacoeconomics; 1996; 9 Suppl 1():1-8. PubMed ID: 10160111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A methodological perspective on process measures of the quality of medical care.
    Tugwell P
    Clin Invest Med; 1979; 2(2-3):113-21. PubMed ID: 391459
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness measures of major depressive disorder in pharmacoeconomic evaluations.
    Casciano R
    Manag Care Interface; 2003; Suppl B():14-5. PubMed ID: 12647608
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacoeconomics. I].
    Kolár J
    Ceska Slov Farm; 1997 Feb; 46(1):9-13. PubMed ID: 9221090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.